Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis

E-ISSN： 1873-5592|18|15|1800-1804

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.15, 2017-10, pp. : 1800-1804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation in Atherosclerosis: A New Therapeutic Target

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclophilins in Atherosclerosis: A New Therapeutic Target?

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5904-5908

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Targeting of Platelet-Mediated Cellular Interactions in Atherosclerosis and Inflammation

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 518-531

Bentham Science Publishers

Access to resources Recommend Favorite

A new therapeutic target for atherosclerosis treatment: interview with Uday Saxena

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite